Lipocine (LPCN) Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic Fibrosis
Go back to Lipocine (LPCN) Announces Publication in Journal of Endocrinological Investigation Highlighting the Potential of LPCN 1144 in the Treatment of NASH and Hepatic FibrosisLIPOCINE (NASDAQ: LPCN) | Delayed: 5.20 +0.07 (1.36%) | |||||
---|---|---|---|---|---|---|
Previous Close | $5.13 | 52 Week High | $14.80 | |||
Open | $5.03 | 52 Week Low | $2.51 | |||
Day High | $5.30 | P/E | N/A | |||
Day Low | $4.85 | EPS | $-0.69 | |||
Volume | 49,035 |